United Beauty Group Launches CoolSculpting® in China, Paving the Way for Non-Invasive Fat Reduction

At the beginning of September, Beijing United Lige Medical Investment Co., Ltd. held the launch ceremony for CoolSculpting® at the “Ice Beauty” Blue Cocktail Party hosted at the Hongxiu International Financial Art Museum in Beijing. To date, CoolSculpting® has been sold in more than 72 countries, with global sales exceeding 7,500 units and the number of individuals who have undergone the treatment surpassing 3.5 million.

On August 18, 2016, CoolSculpting® (Bing Meiren) obtained the medical device registration certificate from the China Food and Drug Administration (CFDA). It is currently the only non-invasive fat reduction device approved by both the U.S. FDA and the CFDA, with its indicated function explicitly defined as reduction of the adipose layer. CoolSculpting® (Bing Meiren) holds absolute advantages in terms of safety and efficacy. Utilizing patented controlled-cooling technology, it induces spontaneous apoptosis of adipocytes in the treatment area; these cells are subsequently phagocytosed by macrophages and naturally metabolized out of the body, ultimately achieving a reduction in the number of fat cells. Clinical studies have verified that it can reduce fat in the treated area by up to 24.8% in a single session.

CoolSculpting® holds 52 patents, with 19 U.S. and 80 international patent applications under its intellectual property portfolio. It has also obtained certifications in major international markets, including Canada, Europe, and other countries. More than 60 international clinical studies have been published.

96% of clients reported excellent comfort and virtually no downtime. 95% of clients were satisfied with the treatment results. 92% of clients observed visible results after a single session. 94% of physicians recommend CoolSculpting®.

Union Beauty’s acquisition decision was driven by its recognition of the outstanding attributes of CoolSculpting®. The more distinguished the aesthetic medicine experts, the more discerning they are about the devices they use; only when advanced techniques are paired with premium equipment can 100% efficacy be achieved. It is this mutual recognition between Union Beauty and Lumenis that facilitated the grand inaugural launch event. According to a survey published in the renowned British medical journal The Lancet, China’s obese population has reached 89.6 million, surpassing that of the United States and making China the country with the largest obese population globally. As an increasing number of beauty-conscious individuals focus on body contouring and slimming, Union Beauty sees significant potential in this expansive market and has introduced CoolSculpting® to provide assistance to more people seeking effective body-slimming solutions.

At the launch event, Mr. Li Bin, Chairman of Union Lige Group, fully affirmed Lumenis’s contributions to the medical aesthetics industry. For many years, Lumenis has consistently introduced new concepts and products to the sector, establishing itself as one of the cornerstones of development in medical aesthetics. He expressed his hope that Lumenis will continue to develop more and better products to benefit aesthetic seekers in China and empower aesthetic practitioners nationwide.

At the event, Lumenis awarded United Beauty Group the title of “Authorized Medical Clinical Center for Ice Beauty Cryolipolysis,” and concurrently presented Zhou Zhanchao, Zhao Xiaozhong, Zhao Qiong, and Lu Hong with certificates as “Authorized Clinicians for Ice Beauty Cryolipolysis.”

Mr. Zhai Qiying, President of Lumenis Asia-Pacific, stated that Union Beauty has pioneered a new model. Lumenis will collaborate with Union Beauty, experts, innovative business models, and cutting-edge technologies to drive the increasing maturity of the medical aesthetics industry.

Lumenis places significant emphasis on its CoolSculpting® product, deploying a dedicated project operations partner team to fully assist hospitals and medical aesthetic institutions. This team provides tailored marketing strategies to facilitate the rapid launch of new services. Lumenis’s specialized Product Marketing Management (PMM) team offers comprehensive support, including clinical and operational guidance, treatment room setup assistance, and media support.